| 2025-10-29 |
详情>>
股本变动：
变动后总股本76770.13万股
|
| 2025-10-29 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.26美元,归母净利润-1.94亿美元,同比去年增长-189.1%
|
| 2025-10-29 |
财报披露：
美东时间 2025-10-29 盘后发布财报
|
| 2025-07-31 |
详情>>
业绩披露：
2025年中报每股收益-0.31美元,归母净利润-2.16亿美元,同比去年增长-134.48%
|
| 2025-05-01 |
详情>>
业绩披露：
2025年一季报每股收益-0.1美元,归母净利润-6761.3万美元,同比去年增长17.38%
|
| 2025-03-14 |
股东大会：
将于2025-04-23召开股东大会
会议内容 ▼▲
- 1.To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2026 annual meeting of stockholders or until their respective successors are duly elected and qualified;
2.To approve a non-binding advisory resolution regarding the compensation paid to the Company's named executive officers (“Say on Pay”);
3.To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025;
4.To transact such other business as may properly come before the Annual Meeting or any adjournments thereof.
|
| 2025-03-14 |
股东大会：
将于2025-04-23召开股东大会
会议内容 ▼▲
- 1.To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2026 annual meeting of stockholders or until their respective successors are duly elected and qualified;
2.To approve a non-binding advisory resolution regarding the compensation paid to the Company's named executive officers (“Say on Pay”);
3.To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025;
4.To transact such other business as may properly come before the Annual Meeting or any adjournments thereof.
|
| 2025-03-03 |
详情>>
业绩披露：
2022年年报每股收益-0.46美元,归母净利润-3.28亿美元,同比去年增长-989.49%
|
| 2025-03-03 |
详情>>
业绩披露：
2024年年报每股收益-0.08美元,归母净利润-5322.4万美元,同比去年增长71.82%
|
| 2024-11-07 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.1美元,归母净利润-6725.1万美元,同比去年增长45.05%
|
| 2024-08-07 |
详情>>
业绩披露：
2023年中报每股收益-0.05美元,归母净利润-3790.7万美元,同比去年增长75.87%
|
| 2024-08-07 |
详情>>
业绩披露：
2024年中报每股收益-0.13美元,归母净利润-9214.1万美元,同比去年增长-143.07%
|
| 2024-07-24 |
详情>>
内部人交易：
Nabel Gary J.等共交易6笔
|
| 2024-05-07 |
详情>>
业绩披露：
2024年一季报每股收益-0.12美元,归母净利润-8183.6万美元,同比去年增长-348%
|
| 2024-03-01 |
详情>>
业绩披露：
2023年年报每股收益-0.25美元,归母净利润-1.89亿美元,同比去年增长42.49%
|
| 2024-02-29 |
股东大会：
将于2024-03-28召开股东大会
会议内容 ▼▲
- 1.To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2025 annual meeting of stockholders or until their respective successors are duly elected and qualified;
2.To approve an amendment in the form set forth on Annex A to the Company’s proxy statement for the Annual Meeting (the “Charter Amendment”) to the Company’s amended and restated certificate of incorporation (the “Certificate of Incorporation”) to increase the number of authorized shares of the Company’s common stock, par value $0.01 per share (“common stock”), that may be issued from 1,000,000,000 to 1,250,000,000;
3.To approve a non-binding advisory resolution regarding the compensation paid to the Company’s named executive officers (“Say on Pay”);
4.To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024;
5.To transact such other business as may properly come before the Annual Meeting or any adjournments thereof.
|
| 2024-02-29 |
股东大会：
将于2024-03-28召开股东大会
会议内容 ▼▲
- 1.To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2025 annual meeting of stockholders or until their respective successors are duly elected and qualified;
2.To approve an amendment in the form set forth on Annex A to the Company’s proxy statement for the Annual Meeting (the “Charter Amendment”) to the Company’s amended and restated certificate of incorporation (the “Certificate of Incorporation”) to increase the number of authorized shares of the Company’s common stock, par value $0.01 per share (“common stock”), that may be issued from 1,000,000,000 to 1,250,000,000;
3.To approve a non-binding advisory resolution regarding the compensation paid to the Company’s named executive officers (“Say on Pay”);
4.To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024;
5.To transact such other business as may properly come before the Annual Meeting or any adjournments thereof.
|
| 2023-11-06 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.16美元,归母净利润-1.22亿美元,同比去年增长49.67%
|
| 2023-05-01 |
股东大会：
将于2023-06-22召开股东大会
会议内容 ▼▲
- 1.To elect as directors the twelve nominees named in the attached proxy statement for a term of office expiring at the 2024 annual meeting of stockholders or until their respective successors are duly elected and qualified;
2.To approve a non-binding advisory resolution regarding the compensation paid to the Company’s named executive officers (“Say on Pay”);
3.To approve a non-binding advisory resolution on the frequency of the advisory vote on Say on Pay in future years (“Say on Frequency”);
4.To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023;
5.To transact such other business as may properly come before the Annual Meeting or any adjournments thereof.
|
| 2023-05-01 |
股东大会：
将于2023-06-22召开股东大会
会议内容 ▼▲
- 1.To elect as directors the twelve nominees named in the attached proxy statement for a term of office expiring at the 2024 annual meeting of stockholders or until their respective successors are duly elected and qualified;
2.To approve a non-binding advisory resolution regarding the compensation paid to the Company’s named executive officers (“Say on Pay”);
3.To approve a non-binding advisory resolution on the frequency of the advisory vote on Say on Pay in future years (“Say on Frequency”);
4.To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023;
5.To transact such other business as may properly come before the Annual Meeting or any adjournments thereof.
|
| 2022-06-03 |
股东大会：
将于2022-07-14召开股东大会
会议内容 ▼▲
- 1.To elect as directors the thirteen nominees named in the attached proxy statement for a term of office expiring at the 2023 annual meeting of stockholders or until their respective successors are duly elected and qualified;
2.To approve a non-binding advisory resolution regarding the compensation paid to the Company’s named executive officers (“Say on Pay”);
3.To amend the OPKO Health, Inc. 2016 Equity Incentive Plan (the “2016 Equity Incentive Plan”) to increase the number of shares issuable thereunder from 30,000,000 to 60,000,000;
4.To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022;
5.To transact such other business as may properly come before the Annual Meeting or any adjournments thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-30 |
股东大会：
将于2021-06-24召开股东大会
会议内容 ▼▲
- 1.To elect as directors the twelve nominees named in the attached proxy statement for a term of office expiring at the 2022 annual meeting of stockholders or until their respective successors are duly elected and qualified;
2.To approve a non-binding advisory resolution regarding the compensation paid to the Company’s named executive officers (“Say on Pay”);
3.To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021;
4.To transact such other business as may properly come before the Annual Meeting or any adjournments thereof.
|
| 2020-04-29 |
股东大会：
将于2020-06-25召开股东大会
会议内容 ▼▲
- 1.To elect as directors the nine nominees named in the attached proxy statement for a term of office expiring at the 2021 annual meeting of stockholders or until their respective successors are duly elected and qualified;
2.To approve a non-binding advisory resolution regarding the compensation paid to the Company’s named executive officers (“Say on Pay”);
3.To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2020;
4.To transact such other business as may properly come before the Annual Meeting or any adjournments thereof.
|
| 2019-04-26 |
股东大会：
将于2019-06-20召开股东大会
会议内容 ▼▲
- 1.To elect as directors the nine nominees named in this proxy statement for a term of office expiring at the 2020 annual meeting of stockholders or until their respective successors are duly elected and qualified;
2.To approve an amendment to the Company’s amended and restated certificate of incorporation (the “Certificate of Incorporation”) to increase the number of authorized shares of the common stock that may be issued from 750 million shares to 1 billion shares;
3.To take a non-binding advisory vote to approve the compensation paid to the Company’s named executive officers (“Say on Pay”);
4.To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019;
5.To transact such other business as may properly come before the Annual Meeting or any adjournments thereof.
|
| 2018-09-08 |
复牌提示：
2018-09-07 14:34:38 停牌，复牌日期 2018-09-14 13:15:00
|
| 2018-04-30 |
股东大会：
将于2018-06-21召开股东大会
会议内容 ▼▲
- 1.To elect as directors the nine nominees named in the attached proxy statement for a term of office expiring at the 2019 annual meeting of stockholders or until their respective successors are duly elected and qualified;
2.To take a non-binding advisory vote to approve the compensation paid to the Company’s named executive officers (“Say on Pay”);
3.To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018;
4.To transact such other business as may properly come before the Annual Meeting or any adjournments thereof.
|
| 2017-04-28 |
股东大会：
将于2017-06-15召开股东大会
会议内容 ▼▲
- 1.To elect as directors the eight nominees named in this proxy statement for a term of office expiring at the 2018 annual meeting of stockholders or until their respective successors are duly elected and qualified;
2.To take a non-binding advisory vote to approve the compensation paid to the Company’s named executive officers (“Say on Pay”);
3.To take a non-binding advisory vote on the frequency of the advisory vote on Say on Pay in future years (“Say on Frequency”);
4.To transact such other business as may properly come before the Annual Meeting or any adjournments thereof.
|
| 2016-03-25 |
股东大会：
将于2016-05-05召开股东大会
会议内容 ▼▲
- 1. To elect as directors the ten nominees named in the attached proxy statement for a term of office expiring at the 2017 annual meeting of stockholders and until their respective successors are duly elected and qualified;
2. To consider and vote on a proposal to approve the Company’s 2016 Equity Incentive Plan;
3. To transact such other business as may properly come before the Annual Meeting or any adjournments thereof.
|
| 2015-05-07 |
股东大会：
将于2015-06-18召开股东大会
会议内容 ▼▲
- 1. To elect as directors the ten nominees named in the attached proxy statement for a term of office expiring at the 2016 annual meeting of stockholders and until their respective successors are duly elected and qualified;
2. To transact such other business as may properly come before the Annual Meeting or any adjournments thereof.
|